Welcome Guest
Sign In
Register
Home
Analytical Testing
Clinical Trials
Contract Research
Logistics
Manufacturing
Articles
Facility Tours
News
Events
Videos
Clinical Trials Documentary
A Solid Dosage Future Documentary
Whitepapers/App Notes
Issue Archives
Company Focus
Service Directory
Register
Sign In
Home
Product and Service Directory
Pharmaceutical Testing
Pharmaceutical Physical Testing Products and Services
Pharmaceutical Dissolution Testing Products and Services
Pharmaceutical Dissolution Testing Products and Services
Dissolution testing allows for the examination and prediction of the in-vitro behavior of pharmaceutical formulations. Drug release behavior of pre-formulations is made possible by the use of specialized dissolution equipment. By dissolution testing, a researcher can simulate the behavior of capsule, bead, and enteric-coated tablets in-vitro.
Important Applications of Dissolution Testing
Quality Control
Replicating certain mechanisms of in-vitro drug release
Determining if drug behavior meets regulatory standards
Dissolution simulation when choosing pharmaceutical excipients
Examples of Pharmaceutical Dissolution Equipment
Paddle apparatus dissolution testing is used to simulate tablet behavior in the gastrointestinal tract. The release behavior of implants and transdermal medications can also be tested with dissolution equipment. The reciprocating cylinder dissolution apparatus ("Bio-Dis") is excellent for examining the dissolution behavior of extended release products. Dissolution analysis is key in determining the homogeneity of the final pharmaceutical product. Whether controlled by the bench user or fully automated, the implementation of a dissolution testing protocol is crucial in the final stages of drug development to ensure the efficacy, safety, and marketability of the final compound.
Pharmaceutical Dissolution Testing Products and Services
Pharmaceutical Dissolution Testing Services
Pharmaceutical Solubility Testing and Enhancement Services
News
Representative Environmental Monitoring: Why Monitoring Activities Are Not Interchangeable Within a Contamination Control Strategy
Thursday, October 29, 2026
Environmental monitoring activities should not be assumed to be interchangeable because contamination control questions are not interchangeable. Different contamination control questions require different information. Environmental monitoring exists to generate that information.
read more
The Importance of a Hybrid Testing Approach for Safety Assessments in the NAM-Enabled Era
Thursday, October 29, 2026
For decades, in vivo models have been the standard in preclinical testing before a drug moves to first-in-human (FIH) trials. But a recent evolution in regulatory expectations has accelerated a steady shift away from in vivo testing, in favor of New Approach Methodologies (NAMs).
read more
The Evolving Regulatory Landscape for Cell and Gene Therapies
Thursday, October 29, 2026
The regulatory landscape for CGTs is moving towards more explicit, risk-based assessment of intended editing outcomes, off-target activity, and genomic integrity. This evolution reflects both the promise of new editing technologies and the need to understand their potential consequences in ...
read more
Building Resilient Pharma Supply Chains to Strengthen Patient Healthcare
Thursday, October 29, 2026
Continuity of care is generally defined in terms of a patient’s ongoing contact with a clinical team and how smoothly their care progresses between providers. Often overlooked is the pharma supply chain and its role in ensuring this continuity.
read more
The Tough Decisions
Thursday, October 29, 2026
While there are many drugs to make the end of life easier and less painful, the fundamental problem of deciding when to end life is a topic and a decision few want to address.
read more
More News
Featured Videos
Pharma Flash - Biopharm Facility News and Regulatory Updates in this Week’s ...
Check out the top pharma news of the week from our Editor-In-Chief, Mike Auerbach. Watch video: Eli Lilly Chooses Vendor for Single-Use Facility and FDA Approves OTC oral contraceptive plus more news in this week’s Pharma Flash
Pharma Flash - Berkshire Sterile Add Lyo Capacity and Amneal Gets CRL from FDA
The hottest news – brought to you quickly – watch this week’s episode of the Pharma Flash
More Videos
Featured Products and Services
We're sorry, no matching articles were found. Please select different filter options and try your search again.
More Featured Products
Featured Articles
We're sorry, no matching articles were found. Please select different filter options and try your search again.
Subscriptions
Get started here for your complimentary print or digital subscription
Sign up Now »